Trade Ipsen - IPN CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.46 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.022079% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | -0.000143% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | EUR | ||||||||
Margin | 5% | ||||||||
Stock exchange | France | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Ipsen SA ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Prev. Close* | 103.07 |
Open* | 103.17 |
1-Year Change* | 0.78% |
Day's Range* | 101.37 - 103.17 |
52 wk Range | 94.85-130.70 |
Average Volume (10 days) | 80.02K |
Average Volume (3 months) | 1.61M |
Market Cap | 8.76B |
P/E Ratio | 21.34 |
Shares Outstanding | 82.64M |
Revenue | 3.28B |
EPS | 4.90 |
Dividend (Yield %) | 1.14833 |
Beta | 0.58 |
Next Earnings Date | Feb 7, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Dec 8, 2023 | 103.07 | 0.70 | 0.68% | 102.37 | 103.57 | 101.57 |
Dec 7, 2023 | 103.67 | 1.30 | 1.27% | 102.37 | 105.07 | 101.57 |
Dec 6, 2023 | 102.87 | 1.20 | 1.18% | 101.67 | 104.57 | 100.67 |
Dec 5, 2023 | 101.77 | 1.80 | 1.80% | 99.97 | 101.87 | 99.97 |
Dec 4, 2023 | 101.37 | 0.90 | 0.90% | 100.47 | 103.17 | 100.47 |
Dec 1, 2023 | 102.07 | -0.80 | -0.78% | 102.87 | 105.07 | 102.07 |
Nov 30, 2023 | 104.17 | 1.50 | 1.46% | 102.67 | 104.57 | 102.57 |
Nov 29, 2023 | 102.57 | 0.30 | 0.29% | 102.27 | 103.57 | 102.07 |
Nov 28, 2023 | 102.57 | 0.00 | 0.00% | 102.57 | 102.87 | 101.57 |
Nov 27, 2023 | 103.17 | 0.10 | 0.10% | 103.07 | 104.67 | 102.87 |
Nov 24, 2023 | 104.37 | -0.10 | -0.10% | 104.47 | 105.17 | 103.67 |
Nov 23, 2023 | 104.37 | 1.00 | 0.97% | 103.37 | 104.67 | 102.97 |
Nov 22, 2023 | 103.67 | -0.10 | -0.10% | 103.77 | 104.27 | 103.17 |
Nov 21, 2023 | 104.07 | 0.30 | 0.29% | 103.77 | 104.17 | 102.07 |
Nov 20, 2023 | 104.17 | 2.00 | 1.96% | 102.17 | 104.77 | 101.37 |
Nov 17, 2023 | 106.77 | 1.70 | 1.62% | 105.07 | 107.17 | 104.77 |
Nov 16, 2023 | 104.87 | 2.20 | 2.14% | 102.67 | 105.17 | 102.67 |
Nov 15, 2023 | 102.57 | -2.70 | -2.56% | 105.27 | 105.47 | 102.07 |
Nov 14, 2023 | 104.87 | -0.90 | -0.85% | 105.77 | 105.97 | 104.37 |
Nov 13, 2023 | 105.77 | 1.30 | 1.24% | 104.47 | 105.77 | 104.37 |
Ipsen Events
Time (UTC) | Country | Event |
---|---|---|
Wednesday, February 7, 2024 | ||
Time (UTC) 07:30 | Country FR
| Event Full Year 2023 Ipsen SA Earnings Release Full Year 2023 Ipsen SA Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 3156.4 | 2748.6 | 2686.2 | 2692.8 | 2348.4 |
Revenue | 3156.4 | 2748.6 | 2686.2 | 2692.8 | 2348.4 |
Cost of Revenue, Total | 527.7 | 438.6 | 490.6 | 488 | 454.2 |
Gross Profit | 2628.7 | 2310 | 2195.6 | 2204.8 | 1894.2 |
Total Operating Expense | 2423.9 | 1920.8 | 2157.6 | 2728.1 | 1829.1 |
Selling/General/Admin. Expenses, Total | 1039.2 | 916.3 | 971.8 | 1020 | 953.1 |
Research & Development | 445.3 | 424.4 | 405.6 | 388.8 | 302.1 |
Unusual Expense (Income) | 138.6 | 25.6 | 191.9 | 698.4 | 37 |
Other Operating Expenses, Total | 273.1 | 115.9 | 97.7 | 132.9 | 82.7 |
Operating Income | 732.5 | 827.8 | 528.6 | -35.3 | 519.3 |
Interest Income (Expense), Net Non-Operating | -9.3 | -22.7 | -13.1 | -32.6 | -8.9 |
Other, Net | -17.3 | -16 | 13.3 | 29.3 | -16.4 |
Net Income Before Taxes | 705.9 | 789.1 | 528.8 | -38.6 | 494 |
Net Income After Taxes | 593.6 | 630.8 | 546.6 | -58.2 | 385.9 |
Minority Interest | 1.1 | -0.1 | -0.9 | -0.5 | 0.4 |
Equity In Affiliates | -1.5 | 0.4 | -1.5 | 3.7 | 1.1 |
Net Income Before Extra. Items | 593.2 | 631.1 | 544.2 | -55 | 387.4 |
Total Extraordinary Items | 55.4 | 15.5 | 3.8 | 4.2 | 2 |
Net Income | 648.6 | 646.6 | 548 | -50.8 | 389.4 |
Total Adjustments to Net Income | 0.1 | 0.1 | |||
Income Available to Common Excl. Extra. Items | 593.2 | 631.1 | 544.2 | -54.9 | 387.5 |
Income Available to Common Incl. Extra. Items | 648.6 | 646.6 | 548 | -50.7 | 389.5 |
Diluted Net Income | 648.994 | 646.861 | 548 | -50.7 | 389.5 |
Diluted Weighted Average Shares | 83.0978 | 83.3584 | 83.4481 | 83.095 | 83.2265 |
Diluted EPS Excluding Extraordinary Items | 7.14332 | 7.57406 | 6.52142 | -0.66069 | 4.65597 |
Dividends per Share - Common Stock Primary Issue | 1.2 | 1.2 | 1 | 1 | 1 |
Diluted Normalized EPS | 8.54588 | 7.81956 | 8.01618 | 4.80245 | 5.00326 |
Dilution Adjustment | 0.39417 | 0.26139 |
Jun 2023 | Dec 2022 | Jun 2022 | Dec 2021 | Jun 2021 | |
---|---|---|---|---|---|
Total revenue | 1623.1 | 1658.5 | 1497.9 | 1452.3 | 1414.6 |
Revenue | 1623.1 | 1658.5 | 1497.9 | 1452.3 | 1414.6 |
Cost of Revenue, Total | 269.9 | 285.6 | 242.1 | 235.1 | 250.6 |
Gross Profit | 1353.2 | 1372.9 | 1255.8 | 1217.2 | 1164 |
Total Operating Expense | 1327.5 | 1439.8 | 996.6 | 1027.3 | 1002.4 |
Selling/General/Admin. Expenses, Total | 552.7 | 551.9 | 487.3 | 488.2 | 483.4 |
Research & Development | 290.2 | 238.1 | 207.2 | 219.3 | 207.3 |
Unusual Expense (Income) | 29.5 | 137.5 | 3.7 | 23.5 | 4 |
Other Operating Expenses, Total | 185.2 | 226.7 | 56.3 | 61.2 | 57.1 |
Operating Income | 295.6 | 218.7 | 501.3 | 425 | 412.2 |
Interest Income (Expense), Net Non-Operating | -12 | -9 | -9.5 | -10.5 | -11.4 |
Other, Net | -22.1 | 4.9 | -0.5 | -13.9 | 0.1 |
Net Income Before Taxes | 261.5 | 214.6 | 491.3 | 400.6 | 400.9 |
Net Income After Taxes | 205.5 | 210.8 | 382.8 | 337.5 | 301.9 |
Minority Interest | 0.1 | 1.1 | 0 | -0.8 | -0.7 |
Equity In Affiliates | -10.3 | -1 | -0.5 | 0.3 | 0.1 |
Net Income Before Extra. Items | 195.3 | 210.9 | 382.3 | 337 | 301.3 |
Total Extraordinary Items | 0 | 43.3 | 12.1 | 5.5 | 1.2 |
Net Income | 195.3 | 254.2 | 394.4 | 342.5 | 302.5 |
Total Adjustments to Net Income | -0.1 | 0.1 | -0.1 | 0.1 | 1.5 |
Income Available to Common Excl. Extra. Items | 195.2 | 211 | 382.2 | 337.1 | 302.8 |
Income Available to Common Incl. Extra. Items | 195.2 | 254.3 | 394.3 | 342.6 | 304 |
Diluted Net Income | 195.2 | 254.694 | 394.3 | 342.861 | 304 |
Diluted Weighted Average Shares | 83.0638 | 83.01 | 83.1857 | 82.9703 | 83.5165 |
Diluted EPS Excluding Extraordinary Items | 2.35 | 2.54661 | 4.59454 | 4.06605 | 3.62563 |
Dividends per Share - Common Stock Primary Issue | 0 | 1.2 | 0 | 1.2 | 0 |
Diluted Normalized EPS | 2.62909 | 4.17371 | 4.6292 | 4.30467 | 3.6617 |
Dilution Adjustment | 0.39417 | 0.26139 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 2397.6 | 1953.8 | 1578.8 | 1346.5 | 1185.6 |
Cash and Short Term Investments | 1200.3 | 826.4 | 691.4 | 412.6 | 350 |
Cash | 814.7 | 642.5 | 215.4 | 137.4 | |
Cash & Equivalents | 1169.3 | 137.9 | 207.1 | ||
Short Term Investments | 31 | 11.7 | 48.9 | 59.3 | 5.5 |
Total Receivables, Net | 673.7 | 764.5 | 602.8 | 644 | 560.1 |
Accounts Receivable - Trade, Net | 632.5 | 564.3 | 476.2 | 565 | 463 |
Total Inventory | 284.1 | 219.4 | 213.9 | 214 | 198.5 |
Prepaid Expenses | 77.8 | 52.2 | 54.4 | ||
Other Current Assets, Total | 239.5 | 65.7 | 70.7 | 23.7 | 22.6 |
Total Assets | 5614.6 | 4990.5 | 4313 | 4306.9 | 3377.4 |
Property/Plant/Equipment, Total - Net | 581.4 | 647.5 | 646.6 | 679.3 | 474.5 |
Property/Plant/Equipment, Total - Gross | 1058.7 | 1290 | 1196.5 | 1170.7 | 934.5 |
Accumulated Depreciation, Total | -477.3 | -642.5 | -549.9 | -491.4 | -460 |
Goodwill, Net | 579.9 | 623.2 | 592.8 | 632.6 | 395.6 |
Intangibles, Net | 1585.4 | 1370 | 1121.1 | 1383.2 | 1011.9 |
Long Term Investments | 136.3 | 133.2 | 126.7 | 111.4 | 173.6 |
Other Long Term Assets, Total | 334 | 262.8 | 247 | 153.9 | 136.2 |
Total Current Liabilities | 1335.4 | 1228.4 | 1213.1 | 1452.5 | 959.2 |
Accounts Payable | 647.1 | 594.7 | 495.2 | 508.5 | 379.8 |
Accrued Expenses | 254.2 | 200.5 | 206.9 | 185.4 | |
Notes Payable/Short Term Debt | 3.8 | 5.5 | 2.8 | 14.3 | 33.6 |
Current Port. of LT Debt/Capital Leases | 27.7 | 29.8 | 228.9 | 302.6 | 4.1 |
Other Current Liabilities, Total | 656.8 | 344.2 | 285.7 | 420.2 | 356.3 |
Total Liabilities | 2270.6 | 2255.3 | 2181.9 | 2555.8 | 1536.3 |
Total Long Term Debt | 663.8 | 657.8 | 639.1 | 696.3 | 297.9 |
Long Term Debt | 581.8 | 562.8 | 542.7 | 568.2 | 297.9 |
Deferred Income Tax | 77.9 | 101.8 | 79.9 | 107.7 | 19.7 |
Minority Interest | -0.6 | 2.5 | 2.7 | 2 | 2.3 |
Other Liabilities, Total | 194.1 | 264.8 | 247.1 | 297.3 | 257.2 |
Total Equity | 3344 | 2735.2 | 2131.1 | 1751.1 | 1841.1 |
Common Stock | 83.8 | 83.8 | 83.8 | 83.8 | 83.8 |
Additional Paid-In Capital | 122.3 | 122.3 | 122.3 | 741.9 | 741.7 |
Retained Earnings (Accumulated Deficit) | 3193.5 | 2635.9 | 2121.1 | 973.3 | 1105.6 |
Treasury Stock - Common | -107.2 | -123.1 | -102.1 | -72.5 | -63.3 |
Other Equity, Total | 51.6 | 16.3 | -94 | 24.6 | -26.7 |
Total Liabilities & Shareholders’ Equity | 5614.6 | 4990.5 | 4313 | 4306.9 | 3377.4 |
Total Common Shares Outstanding | 82.6392 | 82.497 | 82.7225 | 83.0373 | 83.0651 |
Capital Lease Obligations | 82 | 95 | 96.4 | 128.1 |
Jun 2023 | Dec 2022 | Jun 2022 | Dec 2021 | Jun 2021 | |
---|---|---|---|---|---|
Total Current Assets | 1759.8 | 2397.6 | 2589 | 1953.8 | 1764.2 |
Cash and Short Term Investments | 438.1 | 1200.3 | 1123.2 | 826.4 | 739.6 |
Cash & Equivalents | 413.4 | 1169.3 | 1068.3 | 814.7 | 737.5 |
Short Term Investments | 24.7 | 31 | 54.9 | 11.7 | 2.1 |
Total Receivables, Net | 685.6 | 673.7 | 716.1 | 687.1 | 646.3 |
Accounts Receivable - Trade, Net | 649.4 | 632.5 | 623.8 | 564.3 | 554.6 |
Total Inventory | 350 | 284.1 | 190.1 | 219.4 | 232.7 |
Other Current Assets, Total | 286.1 | 239.5 | 559.6 | 220.9 | 145.6 |
Total Assets | 6090.6 | 5614.6 | 5507.1 | 4990.5 | 4521.5 |
Property/Plant/Equipment, Total - Net | 571.6 | 581.4 | 585.9 | 647.5 | 645.7 |
Property/Plant/Equipment, Total - Gross | 1089.6 | 1058.7 | 1088.2 | 1290 | 1239.3 |
Accumulated Depreciation, Total | -518 | -477.3 | -502.4 | -642.5 | -593.6 |
Goodwill, Net | 681 | 579.9 | 557.4 | 623.2 | 604.4 |
Intangibles, Net | 2547.9 | 1585.4 | 1373.1 | 1370 | 1142.4 |
Long Term Investments | 111.8 | 136.3 | 118.7 | 133.2 | 128.8 |
Other Long Term Assets, Total | 418.5 | 334 | 283 | 262.8 | 236 |
Total Current Liabilities | 1709.8 | 1335.4 | 1374.2 | 1228.4 | 1117 |
Accounts Payable | 746.6 | 647.1 | 577.8 | 594.7 | 518.6 |
Notes Payable/Short Term Debt | 1.2 | 3.8 | 30.6 | 5.5 | 11.5 |
Current Port. of LT Debt/Capital Leases | 178.1 | 27.7 | 29.3 | 29.8 | 180.4 |
Other Current Liabilities, Total | 783.9 | 656.8 | 736.5 | 598.4 | 406.5 |
Total Liabilities | 2686.3 | 2270.6 | 2442.6 | 2255.3 | 2134.9 |
Total Long Term Debt | 345.4 | 663.8 | 671.8 | 657.8 | 640.8 |
Long Term Debt | 274.7 | 581.8 | 584.3 | 562.8 | 550.2 |
Capital Lease Obligations | 70.7 | 82 | 87.5 | 95 | 90.6 |
Deferred Income Tax | 297.6 | 77.9 | 120.7 | 101.8 | 92.1 |
Minority Interest | -1 | -0.6 | 1.6 | 2.5 | 1.7 |
Other Liabilities, Total | 334.5 | 194.1 | 274.3 | 264.8 | 283.3 |
Total Equity | 3404.3 | 3344 | 3064.5 | 2735.2 | 2386.6 |
Common Stock | 83.8 | 83.8 | 83.8 | 83.8 | 83.8 |
Additional Paid-In Capital | 122.3 | 122.3 | 122.3 | 122.3 | 122.3 |
Retained Earnings (Accumulated Deficit) | 3265.1 | 3193.5 | 2896.3 | 2635.9 | 282 |
Treasury Stock - Common | -86.1 | -107.2 | -102.3 | -123.1 | -100.5 |
Other Equity, Total | 19.2 | 51.6 | 64.4 | 16.3 | 1999 |
Total Liabilities & Shareholders’ Equity | 6090.6 | 5614.6 | 5507.1 | 4990.5 | 4521.5 |
Total Common Shares Outstanding | 82.6392 | 82.6392 | 82.497 | 82.497 | 82.7225 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | 647.5 | 646.7 | 548.9 | -50.2 | 389.1 |
Cash From Operating Activities | 973.3 | 917.4 | 771.3 | 627.7 | 570.9 |
Cash From Operating Activities | 336.5 | 246.4 | 234.7 | 161.2 | 142.6 |
Deferred Taxes | -136.3 | -130.6 | 19.2 | ||
Non-Cash Items | 159.2 | 219.7 | 134 | 626.9 | 22.8 |
Changes in Working Capital | -169.9 | -195.4 | -10 | 20.4 | -2.8 |
Cash From Investing Activities | -458.6 | -332 | -163.7 | -1157.3 | -274.3 |
Capital Expenditures | -252.9 | -417.9 | -140.7 | -280.6 | -287.5 |
Other Investing Cash Flow Items, Total | -205.7 | 85.9 | -23 | -876.7 | 13.2 |
Cash From Financing Activities | -164.2 | -421.8 | -307.5 | 550 | -202.2 |
Financing Cash Flow Items | -19.1 | -22.6 | -3.9 | 6.5 | -1.2 |
Total Cash Dividends Paid | -99.3 | -82.9 | -83.2 | -83.2 | -83 |
Issuance (Retirement) of Stock, Net | -11.3 | -36.7 | -36.4 | -16.7 | -7.7 |
Issuance (Retirement) of Debt, Net | -34.5 | -279.6 | -184 | 643.4 | -110.3 |
Foreign Exchange Effects | 5.9 | 5.8 | 0.5 | 7.7 | 7.3 |
Net Change in Cash | 356.4 | 169.4 | 300.6 | 28.1 | 101.7 |
Cash Taxes Paid | 130.7 | 181.1 | |||
Cash Interest Paid | 18.2 | 21.5 |
Dec 2022 | Jun 2022 | Dec 2021 | Jun 2021 | |
---|---|---|---|---|
Net income/Starting Line | 647.5 | 394.3 | 646.7 | 303.3 |
Cash From Operating Activities | 973.3 | 334.3 | 917.4 | 357.2 |
Cash From Operating Activities | 336.5 | 105.8 | 246.4 | 110.3 |
Deferred Taxes | 5.6 | 31.1 | ||
Non-Cash Items | 159.2 | -107.4 | 219.7 | 10.2 |
Changes in Working Capital | -169.9 | -64 | -195.4 | -97.7 |
Cash From Investing Activities | -458.6 | -178.6 | -332 | -77.6 |
Capital Expenditures | -252.9 | -117.9 | -417.9 | -78.6 |
Other Investing Cash Flow Items, Total | -205.7 | -60.7 | 85.9 | 1 |
Cash From Financing Activities | -164.2 | 40.9 | -421.8 | -194.6 |
Financing Cash Flow Items | -19.1 | -3.3 | -22.6 | -2.9 |
Total Cash Dividends Paid | -99.3 | -99.3 | -82.9 | -82.9 |
Issuance (Retirement) of Stock, Net | -11.3 | -6.5 | -36.7 | -5.8 |
Issuance (Retirement) of Debt, Net | -34.5 | 150 | -279.6 | -103 |
Foreign Exchange Effects | 5.9 | 31.9 | 5.8 | 1.4 |
Net Change in Cash | 356.4 | 228.5 | 169.4 | 86.4 |
Cash Taxes Paid | 130.7 | 181.1 | ||
Cash Interest Paid | 18.2 | 21.5 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
Mayroy SA | Corporation | 56.6223 | 47457736 | 0 | 2022-12-31 | LOW |
Parvus Asset Management Europe Limited | Investment Advisor/Hedge Fund | 5.056 | 4237680 | 47337 | 2023-04-27 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 1.1881 | 995780 | 748 | 2023-09-30 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 1.0031 | 840782 | 20066 | 2022-12-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.9999 | 838089 | -3321 | 2023-09-30 | LOW |
Oddo BHF Asset Management S.A.S | Investment Advisor/Hedge Fund | 0.998 | 836459 | 55248 | 2023-09-30 | LOW |
BlackRock Advisors (UK) Limited | Investment Advisor/Hedge Fund | 0.5822 | 487971 | -2828 | 2023-09-30 | LOW |
Black Creek Investment Management, Inc. | Investment Advisor | 0.3742 | 313611 | -25493 | 2023-06-30 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.3711 | 311058 | 3005 | 2023-09-30 | LOW |
Liontrust Investment Partners LLP | Investment Advisor | 0.3711 | 311011 | 13076 | 2023-08-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.3216 | 269542 | 7 | 2023-09-30 | LOW |
Ipsen S.A. Employees | Corporation | 0.2802 | 234860 | -38994 | 2022-12-31 | LOW |
Charles Schwab Investment Management, Inc. | Investment Advisor | 0.2321 | 194517 | 2096 | 2023-09-30 | LOW |
BlackRock Investment Management (UK) Ltd. | Investment Advisor/Hedge Fund | 0.2172 | 182043 | 0 | 2023-08-31 | LOW |
Goldman Sachs Asset Management, L.P. | Investment Advisor | 0.2142 | 179541 | 342 | 2023-09-30 | LOW |
Schroder Investment Management Ltd. (SIM) | Investment Advisor/Hedge Fund | 0.2103 | 176249 | 0 | 2023-09-30 | LOW |
Amundi Asset Management, SAS | Investment Advisor/Hedge Fund | 0.202 | 169285 | 3005 | 2023-09-30 | LOW |
M&G Investment Management Ltd. | Investment Advisor | 0.1908 | 159882 | -12698 | 2023-07-31 | LOW |
CPP Investment Board | Pension Fund | 0.1873 | 157000 | 157000 | 2023-03-31 | LOW |
Florida State Board of Administration | Pension Fund | 0.184 | 154185 | 65455 | 2022-09-30 | LOW |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Ipsen Company profile
Founded in 1929, Ipsen (IPN) is a leading international biopharmaceutical group, focusing on specialty care. The company develops and produces innovative medicines in 3 major areas: rare diseases, neurosciences and oncology. Ipsen also runs a consumer healthcare business. In general, the company sells over 20 drugs in more than 115 countries worldwide. Ipsen's R&D is focused on its differentiated and innovative technological platforms in the leading biotechnological hubs, based in Cambridge, the US, Oxford, the UK, and Paris-Saclay, France. Headquartered in Paris, the company employs 5,100 specialists. Included to the CAC Mid 60 index, the Ipsen share price (IPN) is set and traded on the Euronext Paris exchange.Industry: | Pharmaceuticals (NEC) |
65 Quai Georges Gorse
92100
Income Statement
- Annual
- Quarterly
News

December RBA preview: no move expected at the final meeting of 2023
The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.
14:47, 4 December 2023
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
12:39, 30 November 2023
Euro Zone CPI expected to continue dropping; economists warn about cutting too soon
EZ PI expected to drop further but speed of decline
08:16, 29 November 2023
A weaker Dollar drives gold higher
Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.
13:49, 28 November 2023
Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain
US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.
13:20, 28 November 2023
RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023
The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.
13:04, 28 November 2023
Crude prices slide on OPEC+ uncertainty
Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.
12:55, 28 November 2023People also watch
Still looking for a broker you can trust?
Join the 570.000+ traders worldwide that chose to trade with Capital.com